Octapeptide analogues of somatostatin inhibit the clonal growth and vasoactive intestinal peptide-stimulated cyclic AMP formation in human small cell lung cancer cells

This publication has 45 references indexed in Scilit:

• Growth inhibition of MXT mammary carcinoma by enhancing programmed cell death (apoptosis) with analogs of LH-RH and somatostatin
  Breast Cancer Research and Treatment, 1989
• Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer
  Breast Cancer Research and Treatment, 1989
• In vitro and in vivo inhibition of human small cell lung carcinoma (NCl-H69) growth by a somatostatin analogue
  Biochemical and Biophysical Research Communications, 1988
• High affinity binding of [125I-Tyr11]somatostatin-14 to human small cell lung carcinoma (NCI-H69)
  Life Sciences, 1988
• Somatostatin inhibits VIP‐ and isoproterenol‐stimulated cyclic AMP accumulation in rat prostatic epithelial cells
  FEBS Letters, 1987
• Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatin
  Life Sciences, 1987
• Somatostatin
  New England Journal of Medicine, 1983
• Somatostatin
  New England Journal of Medicine, 1983
• Interactions between growth hormone-releasing factor, prostaglandin E2 and somatostatin on cyclic AMP accumulation in rat adenohypophysial cells in culture
  Molecular and Cellular Endocrinology, 1983
• Growth hormone-releasing factor stimulates adenylate cyclase activity in the anterior pituitary gland
  Life Sciences, 1983